Q4 2024 Earnings Call Transcript February 13, 2025 West Pharmaceutical Services, Inc. beats earnings expectations. Reported ...

BofA lowered the firm’s price target on West Pharmaceutical (WST) to $285 from $355 and keeps a Buy rating on the shares after the company ...

At its present level of around $200, WST stock is trading at just 5.1x trailing revenue, compared to its five-year average ...

We recently compiled a list of the Weak Earnings, Outlook Drag Shares of These 10 Firms on Thursday. In this article, we are ...

West Pharmaceutical Services, Inc. reported an EPS of $1.82, beating the estimated $1.71 and showcasing its ability to exceed expectations. The company achieved a revenue of approximately $748.8 ...

West Pharmaceutical Services (WST) stock plummeted 38% on Thursday, making it the biggest decliner in the S&P 500. The sharp ...

Shares of Health Care sector company West Pharmaceutical Services moved -30.7% today, and are now trading at a price of ...

Discover key insights from West Pharmaceutical Services' Q4 2024 earnings call, highlighting growth in GLP-1 elastomers, biologics, and HVP components.

What Happened? Shares of healthcare products company West Pharmaceutical Services (NYSE:WST) fell 34.9% in the afternoon ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Adding fluorine to drug molecules can be tricky, but is often worthwhile. Rachel Brazil talks to the chemists trying to tame ...

West Pharmaceutical Services Inc. closed 20.09% short of its 52-week high of $413.56, which the company reached on February ...